Kingdon Capital Management, L.L.C. Rapt Therapeutics, Inc. Call Options Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $2.95 Million - $3.95 Million	-100,000 Reduced 50.0%	100,000 $3.67 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $899,499 - $2 Million	50,000 Added 33.33%	200,000 $6.36 Million
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $2.4 Million - $3.67 Million	150,000 New	150,000 $3.33 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $51.3M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.